NAS:RXRX (USA)
Â
Class A
$
6.53
-0.010 (-0.15%)
11:20 AM EST
Recursion Pharmaceuticals Inc (NAS:RXRX) Stock News, Headlines & Updates
Recursion Pharmaceuticals Inc Stock News from GuruFocus
- 1
- 2
Jul 21, 2025
Recursion Pharmaceuticals (RXRX) Sees Significant Stock Boost | RXRX Stock News
GuruFocus News • 11:16am
Recursion Pharmaceuticals (RXRX) Sees Significant Stock Price Surge | RXRX Stock News
GuruFocus News • 9:16am
Jul 18, 2025
RXRX Sees Surge in Bullish Options Activity | RXRX Stock News
GuruFocus News • 10:15am
Jul 15, 2025
Recursion Pharmaceuticals (RXRX) Sees Bullish Options Activity Amid Rising Implied Volatility | RXRX Stock News
GuruFocus News • 11:18am
Jul 08, 2025
RXRX Experiences Surge in Options Activity with Rising Implied Volatility | RXRX Stock News
GuruFocus News • 2:30pm
Recursion Pharmaceuticals (RXRX) Stock Surges Due to Drug Ownership Acquisition
GuruFocus News • 12:51pm
Recursion Pharmaceuticals (RXRX) Receives Analyst Support with "Buy" Rating | RXRX Stock News
GuruFocus News • 10:34am
Recursion Pharmaceuticals Acquires Full Interest in ENPP1 Inhibitor Program from Rallybio | RXRX stock news
GuruFocus News • 8:28am
Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
Marketwired • 7:00am
Jul 03, 2025
Recursion Pharmaceuticals (RXRX) Receives New Rating from Morgan Stanley | RXRX Stock News
GuruFocus News • 1:30pm
Jun 16, 2025
Recursion Pharmaceuticals (RXRX): Morgan Stanley Adjusts Price Target | RXRX Stock News
GuruFocus News • 11:30am
Recursion Pharmaceuticals (RXRX): Price Target Cut by Morgan Stanley | RXRX Stock News
GuruFocus News • 7:30am
Jun 10, 2025
Recursion Pharmaceuticals (RXRX) Stock Rises on Cost-Cutting Strategy
GuruFocus News • 3:50pm
Recursion Pharmaceuticals (RXRX) Announces Workforce Reduction to Extend Cash Runway
GuruFocus News • 6:56am
Recursion Pharmaceuticals (RXRX) Implements Workforce and Operational Changes | RXRX Stock News
GuruFocus News • 5:31am
Jun 06, 2025
Recursion Pharmaceuticals (RXRX) Sees Surge in Bullish Options Activity | RXRX Stock News
GuruFocus News • 10:45am
Recursion (RXRX) Shares Jump on New Biomolecular Model Launch
GuruFocus News • 9:55am
MIT and Recursion Release Boltz-2: Next Generation AI Model to Predict Binding Affinity at Unprecedented Speed, Scale, and Accuracy | RXRX Stock News
GuruFocus News • 9:15am
MIT and Recursion Release Boltz-2: Next Generation AI Model to Predict Binding Affinity at Unprecedented Speed, Scale, and Accuracy
Marketwired • 9:00am
Jun 04, 2025
Recursion Pharmaceuticals Inc (RXRX) Announces Promising Early Phase 2 Results for FAP Treatment | RXRX stock news
GuruFocus News • 2:00pm
AI in Healthcare Just Crossed a Tipping Point. Investors Are Watching These Names
PRNewswire • 2:00pm
Recursion Pharmaceuticals (RXRX) Sees Surge in Bullish Options Activity | RXRX Stock News
GuruFocus News • 10:45am
May 30, 2025
Recursion to Participate in Upcoming Investor Conferences | RXRX Stock News
GuruFocus News • 7:20am
Recursion Pharmaceuticals Inc (RXRX) Announces Participation in Key Investor Conferences | RXRX stock news
GuruFocus News • 7:03am
Recursion to Participate in Upcoming Investor Conferences
Marketwired • 7:00am
May 09, 2025
Why Recursion Pharmaceuticals (RXRX) Stock is Sliding Today
GuruFocus News • 4:26pm
May 06, 2025
Why Recursion Pharmaceuticals (RXRX) Stock is Moving Today
GuruFocus News • 2:25pm
Recursion to Participate in Upcoming Investor Conferences
Marketwired • 7:00am
BofA Adjusts Price Target for RXRX Following Pipeline Changes | RXRX Stock News
GuruFocus News • 6:04am
Recursion Pharmaceuticals (RXRX) Sees Adjusted Target Price by Needham | RXRX Stock News
GuruFocus News • 5:00am
Recursion Pharmaceuticals Inc (RXRX) Q1 2025 Earnings Call Highlights: Strategic Partnerships and Financial Resilience
GuruFocus News • 1:03am
Decoding Recursion Pharmaceuticals Inc (RXRX): A Strategic SWOT Insight
GuruFocus News • 11:02pm
Q1 2025 Recursion Pharmaceuticals Inc Earnings Call Transcript
GuruFocus News • 11:00pm
May 05, 2025
Recursion Pharmaceuticals (RXRX) Stock Drops After Earnings Report
GuruFocus News • 2:26pm
Recursion Pharmaceuticals (RXRX) Advances Drug Programs with Strategic Focus
GuruFocus News • 12:57pm
Recursion Pharmaceuticals (RXRX) Reports Q1 Earnings: EPS Surpasses Expectations
GuruFocus News • 5:56am
Recursion (RXRX) Reports Q1 Revenue Shortfall, Focuses on Streamlined Strategy | RXRX Stock News
GuruFocus News • 5:46am
Recursion Pharmaceuticals Q1 2025 Earnings: EPS Beats Estimates at -$0.50, Revenue Misses at $15 Million
GuruFocus News • 5:31am
Recursion Reports First Quarter 2025 Financial Results and Provides Business Update | RXRX Stock News
GuruFocus News • 5:18am
- 1
- 2
Show
Entries
Headlines
Total 0- 1
No recent news